|
US5925376C1
(en)
*
|
1994-01-10 |
2001-03-20 |
Madalene C Y Heng |
Method for treating psoriasis using selected phosphorylase kinase inhibitor and additional compounds
|
|
JP3048642B2
(ja)
*
|
1994-08-03 |
2000-06-05 |
エイ・エス・エイ・シー・ファーマシューティカル・インターナショナル，エイ・アイ・イー |
ウコンの無極性および極性抽出物の取得方法およびその用途
|
|
ES2081264B1
(es)
*
|
1994-08-03 |
1996-08-16 |
A C Pharmaceutical Internation |
Procedimiento para la obtencion de extractos apolares y polares de curcuma y aplicaciones de los mismos.
|
|
ATE227572T1
(de)
*
|
1995-07-14 |
2002-11-15 |
Sabinsa Corp |
Lebenschützende mittel, verfahren zu deren verwendung sowie extraktionsverfahren für curcuminoide
|
|
ZA967730B
(en)
*
|
1995-09-14 |
1998-03-13 |
Res Dev Foundation |
Curcumin (diferuloylmethane) inhibition of NFκB Activation.
|
|
US5861415A
(en)
*
|
1996-07-12 |
1999-01-19 |
Sami Chemicals & Extracts, Ltd. |
Bioprotectant composition, method of use and extraction process of curcuminoids
|
|
GB9711962D0
(en)
*
|
1997-06-10 |
1997-08-06 |
Reckitt & Colmann Prod Ltd |
Therapeutically active compositions
|
|
JP2002500209A
(ja)
|
1998-01-09 |
2002-01-08 |
アイダ ディベロップメント アクティーゼルスカブ |
或る種のジテルペン類そして医薬品として使用するためにこれらを含有するＣｕｒｃｕｍａａｍａｄａの抽出物及び濃縮物
|
|
US6210701B1
(en)
*
|
1999-04-30 |
2001-04-03 |
Healthcomm International, Inc. |
Medical food for treating inflammation-related diseases
|
|
US20010051184A1
(en)
*
|
1999-05-20 |
2001-12-13 |
Madalene C.Y. Heng |
Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases
|
|
US6673843B2
(en)
*
|
1999-06-30 |
2004-01-06 |
Emory University |
Curcumin and curcuminoid inhibition of angiogenesis
|
|
ES2154610B1
(es)
*
|
1999-09-23 |
2001-11-16 |
Asac Compania De Biotecnologia |
Nuevas actividades farmacologicas de los extractos de curcuma longa.
|
|
US20040266883A1
(en)
*
|
1999-10-27 |
2004-12-30 |
Yale University |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
|
US20030149113A1
(en)
*
|
2001-10-12 |
2003-08-07 |
Caplan Michael J. |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
|
US20030236300A1
(en)
*
|
1999-10-27 |
2003-12-25 |
Yale University |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
|
US8076312B2
(en)
*
|
2000-01-10 |
2011-12-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Use of lipid conjugates in the treatment of disease
|
|
US7811999B2
(en)
*
|
2000-01-10 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Use of lipid conjugates in the treatment of diseases
|
|
US9040078B2
(en)
*
|
2000-01-10 |
2015-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Use of lipid conjugates in the treatment of diseases of the nervous system
|
|
US7893226B2
(en)
*
|
2004-09-29 |
2011-02-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Use of lipid conjugates in the treatment of diseases
|
|
US8304395B2
(en)
*
|
2000-01-10 |
2012-11-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Lipid conjugates in the treatment of disease
|
|
US20090325876A1
(en)
*
|
2004-09-29 |
2009-12-31 |
Saul Yedgar |
Use of lipid conjugates in the treatment of diseases associated with vasculature
|
|
US8916539B2
(en)
*
|
2000-01-10 |
2014-12-23 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Use of lipid conjugates in the treatment of disease
|
|
US7608598B2
(en)
|
2000-01-10 |
2009-10-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Use of lipid conjugates in the treatment of conjunctivitis
|
|
US7772196B2
(en)
*
|
2000-01-10 |
2010-08-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Use of lipid conjugates in the treatment of diseases
|
|
US8501701B2
(en)
*
|
2000-01-10 |
2013-08-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of lipid conjugates in the treatment of disease
|
|
WO2001095727A1
(en)
*
|
2000-06-13 |
2001-12-20 |
Wyeth |
Phytonutrient formula for the relief of chronic pain resulting from inflammation
|
|
US6492429B1
(en)
|
2000-07-10 |
2002-12-10 |
N.V. Nutricia |
Composition for the treatment of osteoarthritis
|
|
US8883761B2
(en)
*
|
2001-01-10 |
2014-11-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Use of lipid conjugates in the treatment of diseases associated with vasculature
|
|
KR20020073847A
(ko)
*
|
2001-03-16 |
2002-09-28 |
주식회사 바이오시너젠 |
쿠르쿠민 또는 울금 추출물을 포함하는 치매 예방 및치료용 조성물
|
|
US6387416B1
(en)
*
|
2001-04-05 |
2002-05-14 |
Thomas Newmark |
Anti-Inflammatory herbal composition and method of use
|
|
US20040037903A1
(en)
*
|
2001-06-13 |
2004-02-26 |
Lemmo Edward A. |
Phytonutrient formula for the relief of chronic pain resulting from inflammation
|
|
US6596313B2
(en)
*
|
2001-08-06 |
2003-07-22 |
The Quigley Corporation |
Nutritional supplement and methods of using it
|
|
JP5384777B2
(ja)
*
|
2001-12-18 |
2014-01-08 |
有限会社大長企画 |
強筋肉剤、抗炎症剤
|
|
JP2012149096A
(ja)
*
|
2001-12-18 |
2012-08-09 |
Daicho Kikaku:Kk |
抗炎症剤
|
|
US20090011991A1
(en)
*
|
2002-03-08 |
2009-01-08 |
Emory University |
Novel Curcuminoid-Factor VIIA Constructs as Suppressors of Tumor Growth and Angiogenesis
|
|
US20060229239A9
(en)
*
|
2002-03-08 |
2006-10-12 |
Mamoru Shoji |
Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
|
|
KR20030074017A
(ko)
*
|
2002-03-15 |
2003-09-19 |
한국생명공학연구원 |
쿨쿠민 및 그 유도체의 제조방법 및 이를 유효성분으로함유하는 암의 예방 및 치료용 약학적 조성물
|
|
US6811796B2
(en)
*
|
2002-04-22 |
2004-11-02 |
Matsuura Yakugyo Co., Ltd. |
Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
|
|
WO2003090681A2
(en)
*
|
2002-04-24 |
2003-11-06 |
Research Development Foundation |
SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-κB INHIBITORS AND ANTI-NEOPLASTIC AGENTS
|
|
AU2003253681B2
(en)
*
|
2002-06-24 |
2008-05-01 |
Research Development Foundation |
Treatment of human multiple myeloma by Curcumin
|
|
US7060733B2
(en)
*
|
2002-08-15 |
2006-06-13 |
The Regents Of The University Of California |
Methods for treating pancreatitis with curcumin compounds and inhibitors of reactive oxygen species
|
|
US20040259816A1
(en)
*
|
2002-10-01 |
2004-12-23 |
Pandol Stephen J. |
Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
|
|
EP1638541B1
(en)
*
|
2003-06-27 |
2010-05-19 |
Astellas Pharma Inc. |
Therapeutic agent for soft tissue sarcoma
|
|
CA2536738A1
(en)
*
|
2003-08-26 |
2005-03-10 |
Research Development Foundation |
Aerosol delivery of curcumin
|
|
AU2004320907A1
(en)
|
2003-08-26 |
2006-04-13 |
Research Development Foundation |
Osteoclastogenesis inhibitors and uses thereof
|
|
US20050244522A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Carrara Dario Norberto R |
Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents
|
|
WO2005113069A2
(en)
*
|
2004-05-14 |
2005-12-01 |
Research Development Foundation |
Use of circumin and analogues as inhibitors of acc2
|
|
WO2006020246A1
(en)
*
|
2004-07-23 |
2006-02-23 |
Tsung-Chung Lin |
Anti-hypersensitive inflammation and anti-allergy activities of zingiber zerumbet (l.) smith
|
|
US7514092B2
(en)
*
|
2004-12-22 |
2009-04-07 |
Avon Products, Inc. |
Compositions and methods of their use for improving the condition and appearance of skin
|
|
US20060275516A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Ram A N S |
Compositions and methods for the treatment of allergic rhinitis
|
|
JP5032003B2
(ja)
*
|
2005-06-15 |
2012-09-26 |
株式会社琉球バイオリソース開発 |
口腔粘膜用の鎮痛・抗炎症トローチ剤
|
|
CA2611489A1
(en)
*
|
2005-06-15 |
2006-12-28 |
Darrick S.H.L. Kim |
Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease including sage and rosemary derived compounds
|
|
CA2617484A1
(en)
*
|
2005-08-03 |
2007-02-15 |
Morria Biopharmaceuticals |
Use of lipid conjugates in cystic fibrosis and applications thereof
|
|
WO2007046113A2
(en)
*
|
2005-10-18 |
2007-04-26 |
Panacea Biotec Ltd. |
Novel pharmaceutical composition comprising alkaloid and process thereof
|
|
US8859524B2
(en)
|
2005-11-17 |
2014-10-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Lipid conjugates in the treatment of chronic rhinosinusitis
|
|
US8906882B2
(en)
|
2005-11-17 |
2014-12-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Lipid conjugates in the treatment of allergic rhinitis
|
|
US20070160696A1
(en)
*
|
2006-01-11 |
2007-07-12 |
The Procter & Gamble Company |
Compositions and methods useful for prevention or treatment of respiratory illness
|
|
US20080075671A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Di Mauro Thomas M |
Intranasally administering curcumin to the brain to treat alzheimer's disease
|
|
US20090087385A1
(en)
*
|
2006-09-22 |
2009-04-02 |
Di Mauro Thomas M |
Intranasally administering curcumin in a bolus of helium gas to treat alzheimers disease
|
|
CA2705785A1
(en)
*
|
2006-11-14 |
2008-05-22 |
Saul Yedgar |
Use of lipid conjugates in the treatment of diseases or disorders of the eye
|
|
US8383865B2
(en)
*
|
2007-04-17 |
2013-02-26 |
Codman & Shurtleff, Inc. |
Curcumin derivatives
|
|
JP2010524959A
(ja)
*
|
2007-04-17 |
2010-07-22 |
コドマン・アンド・シャートレフ・インコーポレイテッド |
アルツハイマー病を処置するためのヘリウムガスボーラス中のクルクミンの鼻腔投与
|
|
DE102007047237B4
(de)
*
|
2007-10-02 |
2011-07-14 |
Busch, Klaus-Uwe, Dr. |
Stoffzusammensetzung und deren Verwendung als Mundhygieneprodukt und Nahrungsergänzungsmittel
|
|
WO2009043176A1
(en)
*
|
2007-10-03 |
2009-04-09 |
Sabell Corporation |
Herbal compositions and methods for treating hepatic disorders
|
|
ITMI20072315A1
(it)
*
|
2007-12-11 |
2009-06-12 |
Bios Line Spa |
Composizioni orali per la prevenzione e il trattamento dei disturbi del colon su base infiammatoria
|
|
WO2009080850A1
(es)
|
2007-12-21 |
2009-07-02 |
Asac Compañia De Biotecnologia E Investigacion, S.A. |
Método para aumentar la eficacia terapéutica de los curcuminoides y análogos.
|
|
US7745670B2
(en)
*
|
2008-06-27 |
2010-06-29 |
Codman & Shurtleff, Inc. |
Curcumin-Resveratrol hybrid molecule
|
|
JP5758563B2
(ja)
*
|
2008-03-28 |
2015-08-05 |
丸善製薬株式会社 |
ヒアルロニダーゼ活性阻害剤、及び腫瘍壊死因子産生抑制剤
|
|
US7985776B2
(en)
*
|
2008-06-27 |
2011-07-26 |
Codman & Shurtleff, Inc. |
Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
|
|
CN102215856B
(zh)
*
|
2008-12-01 |
2014-03-05 |
莱拉制药用品私营有限责任公司 |
用于炎症、皮肤病、粘膜病以及其它相关疾病治疗的外用制剂
|
|
US20100150865A1
(en)
*
|
2008-12-11 |
2010-06-17 |
Deepa Chitre |
Novel formulations to inhibit cyclooxygenase and pro-inflammatory cytokine mediated diseases
|
|
US20100286585A1
(en)
*
|
2009-01-26 |
2010-11-11 |
Codman & Shurtleff, Inc. |
Shunt Delivery of Curcumin
|
|
US7723515B1
(en)
*
|
2009-01-26 |
2010-05-25 |
Codman & Shurtleff, Inc. |
Methylene blue—curcumin analog for the treatment of alzheimer's disease
|
|
EP2410999A4
(en)
*
|
2009-03-23 |
2012-04-18 |
Laila Pharmaceuticals Pvt Ltd |
CURCUMINOIDS AND THEIR METABOLIC PRODUCTS FOR ALLERGIC EYE / NOSIS DISEASES
|
|
EP2429532A4
(en)
|
2009-05-11 |
2015-05-27 |
Yissum Res Dev Co |
LIPID / POLYMER CONJUGATES, THEIR PREPARATION AND USES THEREOF
|
|
EP2672828B1
(en)
*
|
2011-02-10 |
2015-04-29 |
Unilever N.V. |
Antimicrobial composition
|
|
KR101416149B1
(ko)
*
|
2011-04-20 |
2014-07-09 |
한국생명공학연구원 |
Ｉｌ－６ 유도 ｓｔａｔ３ 활성화 저해 효과를 갖는 강황 또는 울금의 지상부 추출물, 또는 이의 비극성 유기용매 분획물을 포함하는 조성물
|
|
ITMI20111259A1
(it)
*
|
2011-07-06 |
2013-01-07 |
Eye Tech Srl |
Composizione orosolubile a rapida disgregazione contenente derivati di curcumina
|
|
RU2508118C1
(ru)
*
|
2012-06-27 |
2014-02-27 |
Федеральное государственное казенное военное образовательное учреждение высшего профессионального образования "Военная академия радиационной, химической и биологической защиты имени Маршала Советского Союза С.К. Тимошенко (г. Кострома)" Министерства обороны Российской Федерации |
Способ повышения радиационной устойчивости организма мышей
|
|
US10213382B2
(en)
|
2014-02-03 |
2019-02-26 |
Apurano Pharmaceuticals Gmbh |
Nanosuspension of natural materials and preparation method thereof
|
|
AU2015248504B2
(en)
*
|
2014-04-18 |
2020-07-09 |
Omniactive Health Technologies Limited |
Curcumin compositions and uses thereof
|
|
CN104189725A
(zh)
*
|
2014-07-24 |
2014-12-10 |
汪升静 |
一种治疗小儿哮喘的中药组合物
|
|
JP2015006444A
(ja)
*
|
2014-09-19 |
2015-01-15 |
スミス・アンド・ネフュー・オルソペディクス・アーゲー |
良好な身体応答を示す磨耗粒子を生じる医療用インプラント
|
|
US20200360300A1
(en)
*
|
2014-12-31 |
2020-11-19 |
Signpath Pharma, Inc. |
Suppression of Cytokine Release and Cytokine Storm
|
|
DE102015008823A1
(de)
*
|
2015-07-15 |
2017-01-19 |
Hans Muerth |
Verwendung des Verfahrens und der Vorichtungen zum Verdampfen von Curcumin-Pulver mit einem Hochleistungs-Verdampfer zwecks Erzeugen eines inhalierbaren Curcumin-Aerosols
|
|
RU2743427C1
(ru)
*
|
2020-02-26 |
2021-02-18 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Южно-Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ЮУГМУ Минздрава России) |
Ректальные суппозитории, обладающие противовоспалительным, антиоксидантным, иммуностимулирующим действием, содержащие экстракт корневищ с корнями куркумы длинной
|